Year |
Citation |
Score |
2014 |
Younis IR, George DJ, McManus TJ, Hurwitz H, Creel P, Armstrong AJ, Yu JJ, Bacon K, Hobbs G, Peer CJ, Petros WP. Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancer. Cancer Chemotherapy and Pharmacology. 73: 991-7. PMID 24619498 DOI: 10.1007/S00280-014-2432-X |
0.419 |
|
2012 |
Peer CJ, Younis IR, Leonard SS, Gannett PM, Minarchick VC, Kenyon AJ, Rojanasakul Y, Callery PS. Glutathione conjugation of busulfan produces a hydroxyl radical-trapping dehydroalanine metabolite. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 42: 1170-7. PMID 22725664 DOI: 10.3109/00498254.2012.696740 |
0.675 |
|
2009 |
Younis IR, Stamatakis MK, Callery PS, Meyer-Stout PJ. Influence of pH on the dissolution of folic acid supplements. International Journal of Pharmaceutics. 367: 97-102. PMID 18929632 DOI: 10.1016/J.Ijpharm.2008.09.028 |
0.552 |
|
2008 |
Younis IR, Elliott M, Peer CJ, Cooper AJ, Pinto JT, Konat GW, Kraszpulski M, Petros WP, Callery PS. Dehydroalanine analog of glutathione: an electrophilic busulfan metabolite that binds to human glutathione S-transferase A1-1. The Journal of Pharmacology and Experimental Therapeutics. 327: 770-6. PMID 18791061 DOI: 10.1124/Jpet.108.142208 |
0.702 |
|
2008 |
Cooper AJ, Younis IR, Niatsetskaya ZV, Krasnikov BF, Pinto JT, Petros WP, Callery PS. Metabolism of the cysteine S-conjugate of busulfan involves a beta-lyase reaction. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 1546-52. PMID 18474673 DOI: 10.1124/Dmd.108.020768 |
0.652 |
|
2007 |
Peer CJ, Shakleya DM, Younis IR, Kraner JC, Callery PS. Direct-injection mass spectrometric method for the rapid identification of fentanyl and norfentanyl in postmortem urine of six drug-overdose cases. Journal of Analytical Toxicology. 31: 515-21. PMID 17988466 DOI: 10.1093/Jat/31.8.515 |
0.601 |
|
2006 |
Sanga M, Younis IR, Tirumalai PS, Bland TM, Banaszewska M, Konat GW, Tracy TS, Gannett PM, Callery PS. Epoxidation of the methamphetamine pyrolysis product, trans-phenylpropene, to trans-phenylpropylene oxide by CYP enzymes and stereoselective glutathione adduct formation. Toxicology and Applied Pharmacology. 211: 148-56. PMID 16038959 DOI: 10.1016/J.Taap.2005.06.017 |
0.423 |
|
Show low-probability matches. |